Trials / Completed
CompletedNCT05670067
Alveolar Ridge and Soft Tissue Augmentation Using Graft From the Maxillary Tuberosity
Localized Alveolar Ridge Reconstruction and Soft Tissue Augmentation Using a Triple Graft From the Maxillary Tuberosity Simultaneous With Immediate Implant Placement ( a Randomized Clinical Clinical Study)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Ain Shams University · Academic / Other
- Sex
- All
- Age
- 20 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
In the study immediate implant is placed in the anterior region with autogenous bone grafting from the maxillary tuberosity in one group and in the other group immediate implant is placed with xenograft .IN both groups soft tissue grafting is done using connective tissue assessment of buccal bone thickness and soft tissue will be done 6 months post operative
Detailed description
immediate implant will be placed in the anterior region with autogenous graft from the maxillary tuberosity and in the other group immediate implant will be laced with xenograft soft tissue grafting using sub-epithelial connective tissue will in both groups assessment of buccal bone thickness is the primary outcome of the study, while volumetric assessment of the soft tissue and patient satisfaction are the secondary and tertiary outcome the assessment of all outcome will be 6 months post operative the extraction socket in which the implant will be placed are class I\&II
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | maxillary tuberosity bone graft (autogenous graft) | the usage of maxillary tuberosity as source of autogenous graft supplying the needed cells for bone regeneration |
| PROCEDURE | Bone graft (xenograft) | xenograft is bone graft material that is obtained from porcine, bovine or equine source |
Timeline
- Start date
- 2021-10-30
- Primary completion
- 2024-11-23
- Completion
- 2025-01-05
- First posted
- 2023-01-04
- Last updated
- 2025-03-11
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05670067. Inclusion in this directory is not an endorsement.